|
1
|
Li Y, Liang J, Yang T, Monterrosa Mena J,
Huan C, Xie T, Kurkciyan A, Liu N, Jiang D and Noble PW: Hyaluronan
synthase 2 regulates fibroblast senescence in pulmonary fibrosis.
Matrix Biol. 55:35–48. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lasky JA and Ortiz LA: Antifibrotic
therapy for the treatment of pulmonary fibrosis. Am J Med Sci.
322:213–221. 2001.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhao L, Wang X, Chang Q, Xu J, Huang Y,
Guo Q, Zhang S, Wang W, Chen X and Wang J: Neferine, a
bisbenzylisoquinline alkaloid attenuates bleomycin-induced
pulmonary fibrosis. Eur J Pharmacol. 627:304–312. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang HD, Yamaya M, Okinaga S, Jia YX,
Kamanaka M, Takahashi H, Guo LY, Ohrui T and Sasaki H: Bilirubin
ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J
Respir Crit Care Med. 165:406–411. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chen CY, Peng WH, Wu LC, Wu CC and Shihlan
H: Luteolin ameliorates experimental lung fibrosis both in vivo and
in vitro: Implications for therapy of lung fibrosis. J Agric Food
Chemy. 58:11653–11661. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tsai KD, Yang SM, Lee JC, Wong HY, Shih
CM, Lin TH, Tseng MJ and Chen W: Panax notoginseng attenuates
Bleomycin-Induced pulmonary fibrosis in mice. Evid Based Complement
Alternat Med. 2011(404761)2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sener G, Topaloglu N, Sehirli AO, Ercan F
and Gedik N: Resveratrol alleviates bleomycin-induced lung injury
in rats. Pulm Pharmacol Ther. 20:642–649. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li LC and Kan LD: Traditional Chinese
medicine for pulmonary fibrosis therapy: Progress and future
prospects. J Ethnopharmacol. 198:45–63. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xiang J, Cheng S, Feng T, Wu Y, Xie W,
Zhang M, Xu X and Zhang C: Neotuberostemonine attenuates
bleomycin-induced pulmonary fibrosis by suppressing the recruitment
and activation of macrophages. Int Immunopharmacol. 36:158–164.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xiong X, Yang X, Liu Y, Zhang Y, Wang P
and Wang J: Chinese herbal formulas for treating hypertension in
traditional Chinese medicine: Perspective of modern science.
Hypertens Res. 36:570–579. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals, 8th
edition. National Academies Press, Washington, DC, 2011.
|
|
12
|
Ferri F, Parcelier A, Petit V, Gallouet
AS, Lewandowski D, Dalloz M, van den Heuvel A, Kolovos P, Soler E,
Squadrito ML, et al: TRIM33 switches off Ifnb1 gene transcription
during the late phase of macrophage activation. Nat Commun.
6(8900)2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lee GT, Kwon SJ, Lee JH, Jeon SS, Jang KT,
Choi HY, Lee HM, Kim WJ, Kim SJ and Kim IY: Induction of
interleukin-6 expression by bone morphogenetic protein-6 in
macrophages requires both SMAD and p38 signaling pathways. J Biol
Chem. 285:39401–39408. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Karin M and Lin A: NF-kappaB at the
crossroads of life and death. Nat Immunol. 3:221–227.
2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li Q and Verma IM: NF-kappaB regulation in
the immune system. Nat Rev Immunol. 2:725–734. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Wang P, Nie X, Wang Y, Li Y, Ge C, Zhang
L, Wang L, Bai R, Chen Z, Zhao Y and Chen C: Multiwall carbon
nanotubes mediate macrophage activation and promote pulmonary
fibrosis through TGF-β/Smad signaling pathway. Small. 9:3799–3811.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Meyer KC: Pulmonary fibrosis, part I:
Epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med.
11:343–359. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Smith ML: Update on pulmonary fibrosis:
Not all fibrosis is created equally. Arch Pathol Lab Med.
140:221–229. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xu X, Li D, Gao H, Gao Y, Zhang L, Du Y,
Wu J and Gao P: Protective effect of the traditional Chinese
medicine xuesaitong on intestinal ischemia-reperfusion injury in
rats. Int J Clin Exp Med. 8:1768–1779. 2015.PubMed/NCBI
|
|
21
|
Ding Z and Lian F: Traditional Chinese
medical herbs staged therapy in infertile women with endometriosis:
A clinical study. Int J Clin Exp Med. 8:14085–14089.
2015.PubMed/NCBI
|
|
22
|
Yin D, Liu Z, Peng D, Yang Y, Gao X, Xu F
and Han L: Serum containing Tao-Hong-Si-Wu decoction induces human
endothelial cell VEGF production via PI3K/Akt-eNOS signaling. Evid
Based Complement Alternat Med. 2013(195158)2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Qin Y, Li S, Zhao G, Fu X, Xie X, Huang Y,
Cheng X, Wei J, Liu H and Lai Z: Long-term intravenous
administration of carboxylated single-walled carbon nanotubes
induces persistent accumulation in the lungs and pulmonary fibrosis
via the nuclear factor-kappa B pathway. Int J Nanomedicine.
12:263–277. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang D, Yuan W, Lv C, Li N, Liu T, Wang L,
Sun Y, Qiu X and Fu Q: Dihydroartemisinin supresses inflammation
and fibrosis in bleomycine-induced pulmonary fibrosis in rats. Int
J Clin Exp Pathol. 8:1270–1281. 2015.PubMed/NCBI
|
|
25
|
Zhou Y, He Z, Gao Y, Zheng R, Zhang X,
Zhao L and Tan M: Induced pluripotent stem cells inhibit
bleomycin-induced pulmonary fibrosis in mice through suppressing
TGF-β1/Smad-mediated epithelial to mesenchymal transition. Front
Pharmacol. 7(430)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
National Research Council (US) Institute
for Laboratory Animal Research: Guide for the Care and Use of
Laboratory Animals. National Academies Press (US), Washington, DC,
1996.
|
